Extending treatment with Roche’s breast cancer drug Herceptin to two years from the one year current standard is not worth while, trial data showed on Monday, but shortening treatment to six months also looks unlikely to benefit patients. Richard Gelber, HMS professor of pediatrics, at Dana-Farber Cancer Institute, led the trial.
Lewis Lipsitz, HMS professor of medicine at Beth Israel Deaconess Medical Center and Hebrew SeniorLife, addresses the question about the causes of fainting.
Ben Warf, HMS associate professor of surgery at Boston Children’s Hospital, has been named a 2012 MacArthur Foundation Fellow, one of four Boston-area recipients of the “genius grant.”
Patients who have access to doctor’s notes in their medical records are more likely to understand their health issues, recall what the doctor told them and take their medications as prescribed, according to a study. Tom Delbanco, HMS professor of general medicine and primary care and Jan Walker, principal associate in medicine at Beth Israel Deaconess Medical Center, are co-lead authors of the study.
Partners In Health celebrates its 25th anniversary this week and looks back at all the organization has accomplished and what lies ahead in the coming years, including the opening of the Mirebalais National Teaching Hospital in Haiti. Paul Farmer, Kolokotrones University Professor of Global Health and Social Medicine, is one of the cofounders of Partners In Health.
On any given day, children in the U.S. are exposed to nearly four hours of background TV – a finding that experts say may take a toll on children’s development. Michael Rich, HMS associate professor of pediatrics at Boston Children’s Hospital, is quoted.
The Immune Disease Institute Inc. of Boston has officially merged into Children’s Hospital Boston, effectively ending its near 60-year run as an independent nonprofit focused on molecular medical research.
You don’t have to be elderly, or even very old, to develop delirium, a kind of brain attack often accompanied by hallucinations, agitation and disorientation that can exacerbate illness, increase medical costs and even hasten death. Tamara Fong, HMS assistant professor of neurology at Hebrew SeniorLife, is quoted.
For the first time ever, thanks to a handful of drug approvals over the past 2½ years, there are now multiple options for treating advanced prostate cancer. Philip Kantoff, HMS professor of medicine at Dana-Farber Cancer Institute, is quoted.
A protein that drives the generation of new muscle fibers from stem cells during development and after injury paradoxically also appears to be responsible for the gradual decline in our muscles’ ability to repair as we age. Andrew S. Brack, HMS assistant professor of medicine at Massachusetts General Hospital, led the study.
